98%
921
2 minutes
20
Tissue-resident memory T cells (T) play a key role in defense against pathogen invading barrier sites and other non-lymphoid tissues. How T cells are maintained in various tissues, and how they relate to antigen-experienced memory T cells in lymphoid organs are not fully understood. By barcode-based lineage tracing and single-cell transcriptome analysis, we found a distinct population of CD69CD103 virus-specific CD8 T cells in draining lymph nodes (dLNs) following intranasal influenza infection. Intriguingly, these dLN T cells and lung T cells shared similar function-neutral barcode contents and transcriptomic features, implicating local circulation between the lung and dLNs in the maintenance of resident memory. Ablation of CXCR3 from CD8 T cells, which impairs lung T generation, severely reduced the abundance of dLN T cells, suggesting that dLN T cells are connected to lung T cells by retrograde migration. Our screen for chemokines and chemokine receptors implicated the CCR5-CCL5 axis in promoting lung-to-dLN migration. Temporary CCR5 blockade by intratracheal administration of Maraviroc, a CCR5 inhibitor, reduced the abundance of dLN T cells without affecting lung T cells. By intratracheal cell transfer, CCR5-deficient CD8 T cells were found impaired in lung-to-dLN migration. Finally, dLN T cells actively participated in the secondary response and could reconstitute lung T cells following influenza infection. Our results support a model in which lung-to-dLN TRM retrograde migration helps maintain the CD8 memory resident in the respiratory tract and optimizes the local T-cell response to reinfection.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11427-024-2920-y | DOI Listing |
NPJ Vaccines
July 2025
Vaccine Research Institute (VRI), INSERM-U955 (IMRB) Équipe 16, Université Paris-Est Créteil (UPEC), Créteil, France.
Targeting dendritic cells (DCs) with antigens is a promising approach to modulating T follicular helper (Tfh) cells and germinal center (GC) reactions, enhancing vaccine-induced adaptive immune responses, with preclinical studies highlighting a key role of Langerhans cells (LCs) in generating HIV-1-specific antibody responses. This study evaluated the immunogenicity of a Langerin-targeting vaccine (αLang.Env), comprising an anti-mouse Langerin mAb fused to HIV-1 Envelope 96ZM651 gp140 (Env), delivered through various skin immunization routes in mice, and explored the roles of epidermal LCs and dermal cDC1s in adaptive immune responses.
View Article and Find Full Text PDFCell Immunol
September 2025
Henan Collaborative Innovation Center of Stem Cells and Biotherapy, School of Life Sciences and Technology, Xinxiang Medical University, Xinxiang 453003, China. Electronic address:
Objectives: Chloroquine (CQ) has been used to treat rheumatoid arthritis and systemic lupus erythematosus, but its use in multiple sclerosis (MS) is limited by side effects and insufficient efficacy. To enhance treatment outcomes, understanding CQ's therapeutic mechanisms in MS is crucial. Thus, we administered CQ to mice with experimental autoimmune encephalomyelitis (EAE) and investigated its disease-ameliorating effects and underlying cellular mechanisms.
View Article and Find Full Text PDFStem Cell Res Ther
July 2025
Department of Molecular Medicine, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Severe COVID-19 is characterized by thrombo-inflammatory processes within the lung microvasculature. In pursuit of effective treatments, clinical studies explored mesenchymal stromal cells (MSCs) as a promising approach due to their anti-inflammatory, immunomodulatory, and regenerative properties, through their paracrine action.Here, we tested the conditioned medium (CM) derived from human umbilical cord (UC)-MSCs in acute lung injury induced by the spike protein subunit 1 (S1) in ACE2-humanized male mice.
View Article and Find Full Text PDFMatrix Biol
September 2025
Department of Ophthalmology, NYU Grossman School of Medicine, NY, NY, United States; Department of Pathology, NYU Grossman School of Medicine, NY, NY, United States. Electronic address:
Allergic contact dermatitis (ACD) is a delayed-type IV hypersensitivity response driven by innate and adaptive immune cells. While specific immune regulations of these cell types are amply elucidated, their regulations by extracellular matrix (ECM) components and T cell mediated adaptive immunity in ACD remains unclear. Lumican and biglycan are ECM proteoglycans abundant in the dermis and lymph node, known to regulate innate immune myeloid cells, but have not been investigated in lymphoid cell regulations in ACD.
View Article and Find Full Text PDFSci Rep
June 2025
Division of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, 606-8501, Japan.
Combining radiotherapy with immune checkpoint inhibitors is a promising approach to improve the effectiveness of cancer treatment. However, the success rates of these clinical studies are limited. It is essential to determine the optimal irradiation scheme that maximizes the therapeutic effect by taking into account the balance between the positive and negative effects of radiation on immunity.
View Article and Find Full Text PDF